AbbVie Reconsiders $51.1B Shire Deal on Tax Deal

Oct. 15 (Bloomberg) -- Bloomberg’s Matthew Campbell examines the potential breakdown of a deal between AbbVie and Shire as tax rule changes make the agreement less attractive. He speaks on “The Pulse.”

UBS: U.S. Economic Outlook 'Not Particularly Remarkable'
36:52 - Seth Carpenter, chief U.S. economist at UBS Securities, discusses his firm's view of markets and the U.S. economy amid concerns over the Trump Administration's ability to enact major parts of its legislative agenda. He speaks on "Bloomberg Markets." (Source: Bloomberg)
  • Trump's Post-Bannon Relationship With the Alt-Right
  • Trump's White House Not Most Organized, Says Luntz
  • How Bannon's Ouster May Impact Trump's Agenda